NCT06994221 Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
| NCT ID | NCT06994221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Acute Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2024-11-01 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan during hospital stay, as well as serial echocardiography and telephonic follow-ups. Analysed will focus on the characterization of myocardial fibrosis and its correlations with the clinical prognosis in the patients.
Eligibility Criteria
Inclusion Criteria: * Aged 18-75 years old * Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines) * Half male and half female * Undergo CAG and PCI treatment; * Receive either echocardiography or CMR to identify a ventricular aneurysm; * Written informed consent Exclusion Criteria: * Patients under the age of 18 years old; * Patients who are pregnant/breastfeeding; * Patients who has a previous history of allergy to radio tracers.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06994221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06994221 currently recruiting?
Yes, NCT06994221 is actively recruiting participants. Contact the research team at zouzhiguo@renji.com for enrollment information.
Where is the NCT06994221 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06994221 clinical trial?
NCT06994221 is sponsored by RenJi Hospital. The trial plans to enroll 20 participants.